Clinical trial

Evaluation of the Bioavailability of Pramlintide

NCT00042471

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-06-01

PhasePHASE2

Study timeline

Study start (unknown)2002-06-01Date precision: month

Registry last updated2015-09-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Diabetes Mellitus, Type 2unresolved

Interventions

Pramlintide acetateDRUG · verified · RxNorm: pramlintide acetate

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

MinneapolisMinnesota, United States1 OrlandoFlorida, United States1 AustinTexas, United States1 New OrleansLouisiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00042471 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.